Key facts
- Wicked Sheets’s last known valuation is $7.1M (Feb 2025).
- It has raised $4.7M across 1 recorded rounds; the latest was Later Stage VC (Series A2) ($4.7M) in Feb 2025.
- Notable investors include National Institutes of Health, Keyhorse Capital, Flywheel Fund, 0924 Investments, Awesome Fund — 11 tracked in total.
- Wicked Sheets has filed 2 Form Ds with the SEC since 2024, most recently Jan 2025 ($4.2M sold to 29 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Wicked Sheets
Funding rounds
1 roundsAbout Wicked Sheets
Developer of bedding and sleep-related medical products intended to support comfort, hygiene, and daily care needs across age groups. The company offers sensor-enabled incontinence pads, moisture-wicking fabrics, and temperature-regulating bed sheets, enabling households and care providers to manage sleep comfort and in-bed care with consistent performance and durability.
- Industry
- Other Devices and Supplies
- Sector
- Healthcare
- HQ
- Louisville, KY, United States
- Founded
- 2008
- Employees
- 11
- Website
- wickedsheets.com/
- Ownership
- Privately Held (backing)
Wicked Sheets doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Wicked Sheets shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Wicked Sheets in its N-PORT filings yet. We sweep new filings monthly.